TEXT 949-368-5224

The Human Restoration Mission

11,000+ Diseases. 100 Research Navigators. One Connected Evidence System.

Medical knowledge is advancing every day.

New studies are published. New technologies are developed. New treatments are tested. Researchers, physicians, engineers, universities, companies, patients, and nonprofit organizations continue working to move humanity forward.

Yet too much of that knowledge remains fragmented.

A discovery in one disease may never reach researchers studying another condition with a similar mechanism. An engineering solution may remain separated from a medical problem it could help address. A failed experiment may contain an important lesson, but the lesson becomes buried inside thousands of pages. Valuable evidence can remain divided by terminology, specialty, institution, geography, industry, or time.

The information may exist.

The connection may not.

The Human Restoration Mission exists to help close those gaps.

Our First Major Mission

Our first major undertaking is to process more than 11,000 diseases through the Diamond Eye Solution Research Framework.

The objective is to create a structured first-pass evidence system that helps researchers and specialists see:

• what is already known;

• what remains uncertain;

• where evidence conflicts;

• what critical information may be missing;

• which approaches have already been attempted;

• where research has stalled;

• which diseases may share mechanisms, pathways, symptoms, technologies, or possible solutions;

• and which findings deserve deeper scientific investigation.

This first stage is not a claim that 11,000 diseases will be clinically solved in 10–11 months.

It is the beginning of building the map needed to see where stronger paths may exist.

Because before humanity can responsibly pursue better answers, it must be able to see the full problem clearly.

 

The First 100 Build the Map

A team of approximately 100 research navigators will work in coordinated research pods over an estimated 10–11-month initial campaign.

Not every disease requires the same amount of work.

Some conditions may have concentrated research, clearly documented mechanisms, and well-established treatment paths. Their initial review may take less than an hour.

Others may involve:

• multiple disease subtypes;

• conflicting scientific theories;

• incomplete datasets;

• decades of failed trials;

• genetic and environmental interactions;

• overlooked patient groups;

• competing diagnostic models;

• or potential connections across several fields.

Those diseases may require multiple researchers working together over several days.

The work will therefore be assigned according to complexity, divided into manageable batches, measured through weighted research units, and reviewed through defined quality-control standards.

Straightforward files can continue moving while deeper cases are assigned to specialized teams.

The goal is not speed without substance.

The goal is disciplined scale.

What the Initial Research Will Do

Each disease will move through a consistent framework designed to organize the evidence and reveal what may deserve further attention.

The initial review may examine:

• current biological understanding;

• known genetic and environmental factors;

• disease progression;

• diagnostic methods;

• available treatments;

• treatment limitations;

• failed or inconclusive approaches;

• active research directions;

• major contradictions;

• missing evidence;

• shared mechanisms with other diseases;

• overlooked technologies;

• possible cross-industry solutions;

• potential intervention points;

• paradigm-shift questions;

• evidence strength;

• uncertainty;

• and recommended next steps.

Completed findings can then enter the Cross-Disease Atlas, where relationships between diseases, mechanisms, technologies, failures, and potential solutions can be studied together.

The first 100 people build the map.

The strongest paths then move forward.

From Mapping to Real Investigation

The initial disease review is only the beginning.

Promising findings may require additional rounds involving:

1. deeper Diamond Eye synthesis;

2. independent scientific and medical review;

3. computational or data-based testing;

4. retrospective analysis of existing research;

5. laboratory investigation;

6. engineering development;

7. experimental validation;

8. clinical consideration;

9. regulatory pathways;

10. responsible real-world translation.

Diamond Eye is not being built to replace physicians, researchers, laboratories, universities, engineers, companies, or existing institutions.

It is being built to help connect their work.

A specialist may possess extraordinary depth in one field while never seeing a relevant discovery hidden inside another. A company may have a useful technology without realizing where else it could help. A researcher may be asking the right question but lack access to the missing piece.

Our role is to help organize the fragments, identify the gaps, and bring stronger questions and possible paths to the people qualified to investigate them.

What Your Support Helps Build

Contributions to the Human Restoration Mission will help fund the people, infrastructure, review, and operating systems required to begin responsibly.

Funding may support:

• research navigators and research-pod leaders;

• scientific, medical, engineering, and specialist review;

• evidence collection and source organization;

• data infrastructure and research databases;

• software and responsible AI-assisted research tools;

• evidence-quality scoring and validation;

• contradiction and gap analysis;

• cross-disease and cross-industry synthesis;

• cybersecurity and provenance systems;

• legal, ethical, privacy, and compliance guidance;

• public progress reporting;

• research archives and historical records;

• collaboration with universities, laboratories, companies, and nonprofit organizations;

• deeper investigation of high-value findings;

• experimental and translation reserves;

• and the continued development of the Diamond Eye research infrastructure.

Funding will be activated in phases.

We do not intend to wait for the entire long-term mission budget before beginning meaningful work.

Each funding milestone will support a defined level of staffing, infrastructure, research coverage, validation, and expansion. Progress, costs, lessons, and updated projections can then be reported as the work develops.

The pilot will refine the assumptions.

The evidence will determine what expands.

Why the Gaps Matter

Many serious problems are not caused by a complete absence of knowledge.

They are caused by knowledge that is:

• divided;

• buried;

• outdated;

• difficult to compare;

• poorly transferred;

• trapped inside one specialty;

• disconnected from newer technology;

• or never examined from the right combination of perspectives.

A possible medical solution may come from biology.

It may also come from neuroscience, robotics, materials science, mathematics, physics, energy, environmental science, software, manufacturing, mobility engineering, or a field that does not yet realize it holds part of the answer.

A mobility problem may require more than medicine.

A neurological condition may benefit from discoveries in sensing, rehabilitation, materials, or adaptive technology.

A chronic-disease challenge may involve treatment, environment, behavior, diagnostics, access, timing, and support systems simultaneously.

The Human Restoration Mission is designed to investigate problems across those boundaries.

Because the person living with the problem does not experience life in separate academic departments.

Their suffering arrives as one reality.

The solution may also require one connected view.

Medicine Is the Beginning, Not the Boundary

The first major deployment begins with disease because human suffering is urgent and the consequences of fragmented knowledge are enormous.

But the larger mission extends beyond medicine.

Once the framework is tested, strengthened, and responsibly validated, the same evidence-navigation architecture may help investigate gaps in areas such as:

• assistive technology;

• rehabilitation;

• mobility;

• accessibility;

• environmental health;

• food systems;

• housing;

• education;

• public safety;

• engineering;

• energy;

• legal and institutional systems;

• financial stability;

• disaster preparedness;

• and other areas that affect human dignity and potential.

The purpose is not to enter every industry pretending to know more than the people already doing the work.

The purpose is to be present where fragmented evidence, overlooked connections, or unresolved gaps are preventing progress.

Where we can help organize the problem, we should help.

Where we can identify a useful connection, we should bring it forward.

Where another organization is better positioned to build the solution, we should work with them.

Where a responsible product or technology can be developed, we should explore how to make it real.

The mission succeeds when people receive better outcomes, regardless of who ultimately delivers them.

This Is a Restoration Mission

Behind every disease name is a human being.

A person with plans.

A family waiting for answers.

A child whose future may depend on what researchers notice next.

A parent trying to preserve independence.

A caregiver carrying more than anyone sees.

A person whose health affects their work, relationships, mobility, confidence, finances, faith, contribution, and ability to become who they were capable of becoming.

That is why this mission is about more than information.

It is about restoration.

Restoring connections between evidence.

Restoring overlooked questions to scientific investigation.

Restoring time to specialists by organizing what would otherwise remain buried.

Restoring dignity to people who have been reduced to diagnoses, statistics, or case numbers.

Restoring function, opportunity, independence, and hope wherever responsible progress becomes possible.

We are not building this to take sides.

We are building it to help truth become useful.

This Is Only the Start

The first 11,000-disease research mission is not the final destination.

It is the first serious proof of what a connected evidence system may be able to accomplish.

We can explain the framework.

We can show the architecture.

We can present the estimates, phases, safeguards, and intended process.

But ultimately, the results must speak louder than anything we can write on a fundraising page.

Hopefully, with Hashem’s help, the work will reveal connections we cannot yet describe, questions that have not yet been asked, gaps that have remained invisible, and possible solutions that deserve the attention of people capable of carrying them forward.

We do not claim to know exactly what the research will uncover.

That is why the investigation matters.

The commitment is to pursue it honestly, document it carefully, challenge it responsibly, and follow the evidence wherever it leads.

Help Build the First Complete Map

The first 11,000-disease research mission is not the final destination.

It is the first serious proof of what a connected evidence system may be able to accomplish.

We can explain the framework.

We can show the architecture.

We can present the estimates, phases, safeguards, and intended process.

But ultimately, the results must speak louder than anything we can write on a fundraising page.

Hopefully, with Hashem’s help, the work will reveal connections we cannot yet describe, questions that have not yet been asked, gaps that have remained invisible, and possible solutions that deserve the attention of people capable of carrying them forward.

We do not claim to know exactly what the research will uncover.

That is why the investigation matters.

The commitment is to pursue it honestly, document it carefully, challenge it responsibly, and follow the evidence wherever it leads.

Help Build the First Complete Map

The first 100 research navigators will help build the initial map.

The core synthesis team will connect the strongest findings.

Scientific, medical, engineering, and institutional partners can help review, challenge, validate, test, and translate what deserves to move forward.

And as the system grows, it can be there to help investigate other gaps where fragmented knowledge is limiting human progress.

This is not a promise that every problem will be solved.

It is a commitment to stop accepting fragmentation as an excuse for failing to look.

Help us turn disconnected knowledge into clearer research paths, stronger collaboration, practical solutions, and greater human restoration.

Support the Human Restoration Mission

The first 100 build the map. The next teams follow the strongest paths.

All glory belongs to Hashem.

 

 

© 2026 Ali Dareshoori / Diamond Eye. All rights reserved.

 

Public educational use is permitted with attribution. Commercial implementation, software development, technical integration, derivative frameworks, training products, consulting products, institutional deployment, industry-specific use, or revenue-generating use requires written permission or a license.

 

Diamond Eye is maintained through versioned records, timestamped archives, cryptographic hashes, protected technical packets, public release history, and field-of-use licensing structures.

 

Suspected unauthorized commercial use may trigger written notice, an opportunity to respond, an opportunity to provide independent-origin proof, hardship/good-faith review where appropriate, licensing options, platform notices, public defensive disclosure, competitor field-of-use licensing, attorney correspondence, claims, counterclaims, and all remedies available under applicable law.

 

False claims, harassment, defamatory statements, and bad-faith takedowns are not authorized. Any enforcement action should be evidence-based and lawful.

 

 

———-

DIAMOND EYE COMMERCIAL USE / MISAPPROPRIATION WARNING NOTICE

 

 

Diamond Eye materials are shared in layered form for public benefit, education, research discussion, personal development, and non-commercial learning.

 

Commercial use is different.

 

Any commercial implementation, software development, technical integration, institutional deployment, consulting product, training product, derivative framework, revenue-generating use, field-specific adaptation, or patent filing based on Diamond Eye materials requires written permission, a license, or a partnership agreement with the originator.

 

This includes, but is not limited to, using Diamond Eye concepts, names, language, diagrams, formulas, workflows, architecture, documentation, proof-ledger structures, route-protection logic, source-chain logic, hidden-hinge logic, landing-zone logic, correction-window logic, frame-refusal logic, chameleon-adaptation logic, industry-specific adaptations, software systems, dashboards, AI tools, operational procedures, commercial training, consulting offers, investment materials, pitch decks, research proposals, product roadmaps, or derivative frameworks.

 

Diamond Eye is maintained through versioned records, timestamped archives, cryptographic hashes, private master packets, public release history, protected technical files, and field-of-use licensing structures.

 

Diamond Eye may also be maintained through invention notes, dated drafts, preserved message records, internal technical packets, public-facing versions, protected versions, hash logs, archive records, email records, publication records, domain-specific adaptations, and other provenance materials used to establish origin, authorship, development sequence, disclosure history, and commercial boundaries.

 

If unauthorized commercial use, misappropriation, false authorship, derivative commercialization, or attempted capture of the framework is identified, the originator intends to follow a documented lawful response process before legal escalation whenever practical.

 

That process may include:

 

1. NOTICE

 

The suspected party may receive written notice identifying the alleged use, copied structure, derivative material, commercial deployment, or disputed claim.

 

The notice may identify the relevant Diamond Eye material, the suspected overlap, the commercial use, the derivative structure, the public-facing product, the platform, the publication, the pitch, the filing, the software, the consulting offer, the training product, the technical integration, the institutional deployment, or the revenue-generating activity at issue.

 

The purpose of notice is to provide a clear opportunity to understand the concern before escalation.

 

2. OPPORTUNITY TO RESPOND

 

The suspected party may be given an opportunity to explain whether the use is educational, independent, internal, commercial, licensed, mistaken, or otherwise lawful.

 

The suspected party may explain whether the use was accidental, independently developed, non-commercial, research-based, internal only, already licensed, based on public principles only, or based on separate lawful origin.

 

The originator may review the response in good faith without waiving any rights, remedies, claims, notices, filings, defenses, counterclaims, licensing options, or lawful enforcement pathways.

 

3. OPPORTUNITY TO PROVIDE PROOF

 

The suspected party may be invited to provide dated records, development history, independent invention evidence, source materials, internal documentation, or other proof showing lawful independent origin or authorized use.

 

Proof may include dated drafts, internal records, invention notes, technical development history, source files, version history, repository records, research notes, prior publications, communications, contracts, licenses, assignment records, design documents, or other materials showing independent development, lawful authorization, or non-commercial purpose.

 

Failure to provide proof when requested may be considered as part of the originator’s evaluation of whether further action is appropriate.

 

4. HARDSHIP / GOOD-FAITH REVIEW

 

If the suspected party is a small operator, individual, student, researcher, startup, or financially distressed party, they may request a good-faith hardship review before escalation. Supporting information may be requested to evaluate the claim, such as business status, revenue status, funding status, and intended use. This does not waive any rights, but it may support a reduced-cost license, attribution correction, delayed payment, cure period, or non-commercial permission where appropriate.

 

Hardship review may also consider whether the party acted in good faith, whether the use was accidental, whether the use was non-commercial, whether the party is a student or researcher, whether there is actual revenue, whether the party has funding, whether the party is a small operator, whether the party is willing to correct attribution, whether the party is willing to stop commercial use, whether the party is willing to enter a license, and whether the use can be cured without escalation.

 

Supporting information may include business status, funding status, revenue status, commercialization status, product status, user count, investor involvement, intended use, public statements, sales materials, and any other information reasonably relevant to determine whether a hardship or good-faith resolution is appropriate.

 

Hardship review is voluntary. Hardship review does not waive ownership claims, authorship claims, commercial rights, licensing rights, enforcement rights, defensive disclosure rights, platform notice rights, contract rights, claims, counterclaims, or any remedies available under applicable law.

 

5. LICENSING OPTION

 

Where appropriate, the suspected party may be offered a written license, pilot agreement, field-of-use agreement, attribution agreement, settlement agreement, or other lawful resolution.

 

A license may be limited by industry, field of use, product type, territory, term, platform, customer class, revenue model, internal use, pilot use, research use, or commercial deployment.

 

A license may also require attribution, reporting, payment, audit rights, non-sublicensing restrictions, non-transfer restrictions, confidentiality obligations, non-disparagement obligations, permitted-use limits, derivative-work limits, patent-filing restrictions, data-use restrictions, and other terms appropriate to the situation.

 

Commercial users are expected to come through the front door.

 

6. FAILURE TO RESPOND

 

If the suspected party ignores the notice, refuses to provide proof, continues commercial use without permission, falsely claims ownership, removes attribution, or attempts to monopolize the framework, the originator reserves the right to proceed with lawful escalation.

 

Failure to respond may include ignoring written notice, refusing to identify the nature of the use, refusing to provide independent-origin proof, continuing revenue-generating activity, expanding commercial use, removing attribution, filing derivative claims, misleading customers, misleading investors, misleading platforms, misrepresenting authorship, or attempting to capture the framework without permission.

 

The originator reserves the right to treat silence, refusal, continued use, false authorship, or commercial expansion as a basis for further lawful action.

 

7. LAWFUL ESCALATION RIGHTS RESERVED

 

Depending on the facts and applicable law, escalation may include public clarification of origin, defensive disclosure, platform reports, copyright notices where applicable, trademark notices where applicable, contract claims where applicable, trade-secret claims where applicable, patent-related action where applicable, competitor field-of-use licensing, attorney correspondence, claims, counterclaims, injunction requests, damages requests, and all remedies available under applicable law.

 

Escalation may also include preserving evidence, archiving public materials, documenting similarities, preparing comparison charts, contacting relevant platforms, contacting hosts, contacting repositories, contacting marketplaces, contacting payment processors, contacting app stores, contacting public archives, contacting investors or partners where legally appropriate, issuing clarification statements, publishing version history, publishing defensive disclosures, or making additional public-interest releases to prevent unauthorized capture or false ownership.

 

All lawful rights are reserved.

 

All lawful remedies are reserved.

 

All lawful claims and counterclaims are reserved.

 

All lawful defensive disclosures are reserved.

 

All lawful licensing options are reserved.

 

8. PLATFORM / PUBLIC RECORD NOTICE

 

Where unauthorized commercial use appears on websites, marketplaces, social platforms, app stores, repositories, investor materials, public sales pages, or media channels, the originator reserves the right to submit accurate, evidence-based notices or reports to relevant platforms, hosts, registrars, marketplaces, search engines, app stores, repositories, payment providers, investors, partners, or public archives, where legally appropriate and supported by documentation.

 

Such notices may identify the disputed use, the original Diamond Eye materials, the relevant timestamps, the public release history, the version history, the suspected copied structure, the commercial activity, the missing attribution, the false authorship claim, the derivative product, or the attempted capture of the framework.

 

The originator may also publish accurate public clarification of origin, version history, authorship, and commercial-use boundaries where appropriate.

 

Platform and public-record notices should be evidence-based, proportional, truthful, and lawful.

 

9. NO BAD-FAITH CLAIMS

 

The originator does not support false claims, harassment, defamatory statements, abusive reporting, or bad-faith takedowns. Any enforcement step should be based on documented evidence and pursued to the fullest extent permitted by law.

 

Nothing in this notice authorizes false accusations, fabricated evidence, harassment, threats, defamatory statements, abusive mass-reporting, bad-faith platform reports, unlawful interference, or improper pressure.

 

Any enforcement action should be evidence-based, documented, proportional, and lawful.

 

The purpose of this notice is to distinguish public benefit use from unauthorized commercial exploitation.

 

10. PUBLIC BENEFIT DISTINCTION

 

Individuals may learn.

 

Students may study.

 

Researchers may discuss.

 

People may use the public principles for personal development and non-commercial education with attribution.

 

Companies, institutions, funded teams, commercial actors, and revenue-generating users must license the engine.

 

Public learning is welcome.

 

Human benefit is welcome.

 

Non-commercial education is welcome.

 

Research discussion is welcome.

 

Attribution is expected.

 

Commercial exploitation without permission is not welcome.

 

All rights, remedies, notices, filings, claims, counterclaims, licensing options, defensive disclosures, and lawful enforcement pathways are expressly reserved.

 

11. SEVEN-LAYER DISCLOSURE AND DEFENSE STRUCTURE

 

Diamond Eye may be maintained through a layered disclosure and defense structure.

 

Layer One may include public principle materials shared for education, human benefit, personal development, and non-commercial use with attribution.

 

Layer Two may include public technical abstracts shared for open discussion of the problem, claim, framework, and validation direction.

 

Layer Three may include protected technical briefs shared only under protected review terms, licensing discussions, pilot discussions, or other controlled conditions.

 

Layer Four may include master technical packets reserved for patent counsel, authorized technical partners, protected collaborators, licensed pilots, and internal development.

 

Layer Five may include field-of-use implementation packets reserved for industry-specific licensed deployment, including aerospace, logistics, manufacturing, medical trajectory, legal audit, business risk, AI decision systems, security, or other domains.

 

Layer Six may include defensive evidence packets maintained for provenance, authorship, timestamp proof, hash history, publication trail, comparison mapping, claim support, and enforcement support.

 

Layer Seven may include public defensive releases reserved for situations where unauthorized parties attempt to misappropriate, monopolize, falsely claim, commercially exploit, suppress, or capture the framework without permission.

 

The originator reserves the right to publish additional public-interest versions, defensive disclosures, clarifications, industry-specific educational releases, or competitor field-of-use licensing where appropriate to prevent unauthorized capture and preserve public benefit.

 

12. FIELD-OF-USE LICENSING

 

Commercial licensing may be limited by field of use.

 

A field-of-use license may permit use only in a defined industry, product category, territory, customer group, platform, technical environment, pilot project, internal workflow, or commercial deployment.

 

No license should be assumed to cover all Diamond Eye materials, all industries, all versions, all derivative works, all software, all formulas, all implementation methods, all documents, all future versions, all patents, all trade secrets, all copyrights, all trademarks, or all commercial uses unless expressly stated in writing.

 

Commercial parties must not assume that access to public materials grants implementation rights.

 

Commercial parties must not assume that discussion grants license rights.

 

Commercial parties must not assume that review grants deployment rights.

 

Commercial parties must not assume that silence grants permission.

 

Written permission controls.

 

13. ATTRIBUTION AND FALSE AUTHORSHIP

 

Public educational use is permitted with attribution.

 

False authorship is not permitted.

 

Removal of attribution, rebranding of Diamond Eye materials as independently created, false origin claims, misleading customer-facing claims, misleading investor-facing claims, or derivative frameworks presented as original may trigger notice, proof request, platform notice, public clarification, licensing demand, defensive disclosure, or lawful enforcement.

 

Attribution should identify Diamond Eye and the originator where appropriate.

 

14. DERIVATIVE FRAMEWORKS

 

A derivative framework may include any framework, system, software, model, document, product, training, consulting method, dashboard, simulator, architecture, workflow, decision engine, industry adaptation, or technical method that substantially uses, adapts, translates, renames, restructures, or commercializes Diamond Eye materials, concepts, architecture, formulas, labels, proof-ledger logic, route-protection logic, hidden-hinge logic, landing-zone logic, frame-refusal logic, correction-window logic, or field-of-use mappings.

 

Derivative commercial use requires written permission, a license, or a partnership agreement.

 

15. PUBLIC RELEASE AND DEFENSIVE DISCLOSURE

 

The originator reserves the right to release additional public versions of Diamond Eye materials for public benefit, education, defensive disclosure, authorship clarification, anti-monopolization, and prevention of unauthorized capture.

 

Such releases may include additional public abstracts, educational versions, industry-specific versions, correction notes, version histories, authorship records, proof-of-origin materials, public explanatory documents, public clarifications, and other lawful public-interest disclosures.

 

Public defensive disclosure may be used where unauthorized parties attempt to claim, capture, suppress, monopolize, commercialize, or misrepresent the framework without permission.

 

16. NO WAIVER

 

Failure to respond immediately to suspected unauthorized use does not waive any rights.

 

Delay in enforcement does not waive any rights.

 

Public sharing does not waive commercial rights.

 

Educational use permission does not waive commercial rights.

 

Good-faith review does not waive any rights.

 

Hardship review does not waive any rights.

 

Licensing discussion does not waive any rights.

 

Providing notice does not waive any rights.

 

Offering a cure period does not waive any rights.

 

All rights are reserved.

 

17. GOVERNING PRINCIPLE

 

The distinction is simple.

 

People may learn.

 

Students may study.

 

Researchers may discuss.

 

Individuals may use the public principles for personal growth and non-commercial education.

 

Companies, institutions, funded teams, commercial actors, and revenue-generating users must license the engine.

 

Public wisdom is open.

 

Commercial implementation is licensed.

 

Misappropriation activates the documented lawful response process.

 

⸻

 

© 2026 Al Dareshore / IIGA / International Integrity Guardian Alliance / Diamond Eye. All rights reserved.

 

Public educational use is permitted with attribution. Commercial implementation, software development, technical integration, derivative frameworks, training products, consulting products, institutional deployment, industry-specific use, or revenue-generating use requires written permission or a license.

 

Diamond Eye is maintained through versioned records, timestamped archives, cryptographic hashes, protected technical packets, public release history, and field-of-use licensing structures.

 

Suspected unauthorized commercial use may trigger written notice, an opportunity to respond, an opportunity to provide independent-origin proof, hardship/good-faith review where appropriate, licensing options, platform notices, public defensive disclosure, competitor field-of-use licensing, attorney correspondence, claims, counterclaims, and all remedies available under applicable law.

 

False claims, harassment, defamatory statements, and bad-faith takedowns are not authorized. Any enforcement action should be evidence-based and lawful.